In this episode, Bright and Anousha chat with Fiona Borondy-Jenkins, Program Coordinator, and Shreya Koirala, Program Manager, at the Hepatitis B Foundation about their new paper, Boosting Diverse Communities’ Participation in Clinical Trials: What People Living with Hepatitis B Must Know. Together, they discuss the importance of representation in clinical research, barriers that may prevent people from participating in clinical trials, and practical information to help individuals living with hepatitis B make informed decisions about research opportunities.

Support the show

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook

In this episode, we spoke with Dr. Tatyana Kushner, Associate Professor of Medicine in the Department of Gastroenterology at Weill Cornell Medicine in New York. Dr. Kushner discusses hepatitis B treatment during pregnancy, including when antiviral therapy is recommended to help prevent mother-to-child transmission, and the importance of continuing hepatitis B care and treatment after pregnancy to support long-term liver health.

Support the show

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook

In this episode, Bright and Anousha chat with Carl Schmid, Executive Director of the HIV+Hepatitis Policy Institute, about the financial challenges people living with hepatitis B face in the U.S., including high medication costs, insurance barriers, and the ongoing struggle to access affordable, life-saving treatment.

Note:

Carl also shared an important update that at least one widely used hepatitis B medication is now available through Trump Rx for about $20 per month, offering a potentially more affordable option for some patients.

Support the show

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook